Mechanistic insights of the left ventricle structure and fibrosis in the arrhythmogenic mitral valve prolapse

Authors

  • Leticia Fernández-Friera 1 Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain 2 HM Hospitales-Centro Integral de Enfermedades Cardiovasculares HMCIEC, Madrid, Spain
  • Rafael Salguero Hospital Universitario 12 de Octubre, Madrid, Spain
  • Luca Vannini 3 Hospital Universitario 12 de Octubre, Madrid, Spain 4 Universidad Rey Juan Carlos (PhD Etudent in Epidemiology and Public Health), Madrid
  • Ana Fidalgo Argüelles HM Hospitales-Centro Integral de Enfermedades Cardiovasculares HMCIEC, Madrid, Spain
  • Fernando Arribas Hospital Universitario 12 de Octubre, Madrid, Spain
  • Jorge Solís 1 Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain 2 HM Hospitales-Centro Integral de Enfermedades Cardiovasculares HMCIEC, Madrid, Spain 3 Hospital Universitario 12 de Octubre, Madrid, Spain

DOI:

https://doi.org/10.21542/gcsp.2018.4

Abstract

Mitral valve prolapse (MVP) is a common and benign condition. However, some anatomic forms have been recently associated with life-threatening ventricular arrhythmias and sudden cardiac death. Imaging MVP holds the promise of individualized MVP risk assessment. Noninvasive imaging techniques available today are playing an increasingly important role in the diagnosis, prognosis and monitoring of MVP. In this article, we will review the current evidence on arrhythmogenic MVP, with special focus on the utility of echocardiography and CMR for identifying benign and ‘‘malignant’’ forms of MVP. The clinical relevance of this manuscript lies in the value of imaging technology to improve MVP risk prediction, including those arrhythmic-MVP cases with a higher risk of sudden cardiac death. 

Downloads

Published

2018-03-17

Issue

Section

Review articles